AQST Q4 2019 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q4 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$16M-2.4% YoY

Gross Profit

$10M58.6% margin

Operating Income

-$10M-60.3% margin

Net Income

-$13M-77.0% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+32.2%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$78M

Total Liabilities

$85M

Stockholders' Equity

-$6M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$17M	-2.4%
Gross Profit	$10M	$12M	-20.0%
Operating Income	-$10M	-$12M	+19.8%
Net Income	-$13M	-$14M	+9.4%

Revenue Segments

Manufacture and Supply Revenue

$14M85%

Co-Development and Research Fees

$1M7%

Proprietary Product Sales

$682,0004%

License and Royalty Revenue

$557,0003%

Geographic Segments

United States

$15M89%

Non-US

$2M11%